ASML lifts 2026 guidance as Q2 sales rise 21%
ASML lifted its 2026 sales outlook to €43–45 billion, equivalent to 31.6–37.8% growth over 2025, after second-quarter sales rose 21.3% to €9.3265 billion and gross margin reached 54.0%.
The 15 July update was an upward revision, not a neutral reset. ASML beat the top of its April sales and gross-margin guidance, raised the midpoint of its full-year sales range by 15.8%, and outlined more manufacturing capacity for lithography systems used in advanced chip production. The company no longer reports quarterly bookings, so historical order intake can show scale but cannot supply an estimate for the undisclosed 2026 figure.
ASML's Q2 sales have risen by nearly half in two years
ASML's second-quarter 2026 US GAAP statements put sales at €9.3265 billion, up 21.3% from €7.6917 billion in Q2 2025. The Q2 2024 SEC-filed statements show sales of €6.2428 billion. Sales therefore increased 23.2% from Q2 2024 to Q2 2025 and 21.3% in the latest year, a cumulative 49.4% increase and a 22.2% two-year compound annual growth rate.
Service and field-option sales rose even faster, from €1.4819 billion in Q2 2024 to €2.0956 billion in Q2 2025 and €2.7617 billion in Q2 2026. That is an 86.4% two-year increase. These sales represented 23.7%, 27.2% and 29.6% of total sales respectively, showing how revenue from ASML's installed equipment base has become a larger part of the quarterly mix.
ASML Q2
Quarter ended 30 Jun- Total net sales
- €6.2428bn
- Net system sales
- €4.7609bn
- Service and field-option sales
- €1.4819bn
- Gross margin
- 51.5%
- Net income
- €1.5779bn
ASML Q2
Quarter ended 29 Jun- Total net sales
- €7.6917bn
- Net system sales
- €5.5961bn
- Service and field-option sales
- €2.0956bn
- Gross margin
- 53.7%
- Net income
- €2.2903bn
ASML Q2
Quarter ended 28 Jun- Total net sales
- €9.3265bn
- Net system sales
- €6.5648bn
- Service and field-option sales
- €2.7617bn
- Gross margin
- 54.0%
- Net income
- €2.9176bn
The figures are ASML's US GAAP results for quarters ended 30 June 2024, 29 June 2025 and 28 June 2026. Growth and mix calculations use the unrounded euro amounts in the statements. Service and field-option sales are the line ASML also describes as Installed Base Management sales.
Profitability strengthened alongside sales. From Q2 2024 to Q2 2026, gross margin increased from 51.5% to 54.0%, operating margin increased from 29.4% to 37.1%, and net income rose 84.9% to €2.9176 billion. In the latest year alone, operating income grew 29.7%, net income grew 27.4% and basic earnings per ordinary share rose 28.6% to €7.59.
How much ASML raised its full-year outlook
The April release guided to €36–40 billion of 2026 sales and a 51–53% gross margin. Against 2025 sales of €32.667 billion, that sales range represented 10.2–22.4% growth, with 16.3% at its €38 billion midpoint.
The Q2 beat also had a clear installed-base component. Service and field-option sales of €2.7617 billion were €0.2617 billion, or 10.5%, above ASML's approximate €2.5 billion April guide. Gross margin of 54.0% was 2.0 percentage points above the top of the 51–52% range. Management's second-quarter transcript says the installed-base business was about €300 million above expectation and was the main reason sales and margin exceeded Q2 guidance; that is management's rounded description of the same operating upside.
The July release raised the sales range to €43–45 billion, equivalent to 31.6–37.8% growth over 2025 and 34.7% at the €44 billion midpoint. The low end increased €7 billion, or 19.4%; the midpoint increased €6 billion, or 15.8%; and the high end increased €5 billion, or 12.5%. ASML also raised every point of its gross-margin range by 3.0 percentage points, from 51–53% to 54–56%. Range midpoints are arithmetic summaries, not management point forecasts.
The raised outlook points to stronger second-half growth
First-half sales reached €18.0934 billion, up 17.2% from €15.4332 billion a year earlier. The new full-year range implies 31.6–37.8% growth over 2025, so it points to a faster reported growth rate in the second half if ASML delivers within the range.
Subtracting first-half sales from the €43–45 billion outlook gives €24.9066–26.9066 billion of implied second-half sales, displayed below as €24.9–26.9 billion. That would be 44.5–56.1% above the €17.2338 billion reported in the second half of 2025. At the range midpoint, full-year growth would be 34.7% and second-half growth would be 50.3%.
Low end
Full-year reference- FY2026 sales
- €43.0bn
- FY growth vs 2025
- +31.6%
- Implied H2 sales
- €24.9bn
- H2 growth vs 2025
- +44.5%
Midpoint
Arithmetic midpoint- FY2026 sales
- €44.0bn
- FY growth vs 2025
- +34.7%
- Implied H2 sales
- €25.9bn
- H2 growth vs 2025
- +50.3%
High end
Full-year reference- FY2026 sales
- €45.0bn
- FY growth vs 2025
- +37.8%
- Implied H2 sales
- €26.9bn
- H2 growth vs 2025
- +56.1%
The table uses ASML's €32.667 billion of 2025 sales, €15.4332 billion of first-half 2025 sales and €18.0934 billion of first-half 2026 sales. The second-half values are arithmetic residuals, not separate company guidance, and do not prescribe how sales divide between the third and fourth quarters.
ASML guided to €11–12 billion of third-quarter sales, approximately €2.9 billion of service and field-option sales, and a 55–57% gross margin. System acceptance timing, product mix, upgrades and customer schedules can still shift the quarterly path inside the annual range.
Orders and capacity support the higher outlook
ASML stopped disclosing quarterly bookings in 2026 after explaining that purchase-order timing made the number lumpy and not always a reliable measure of business momentum. Across the eight quarters of 2024 and 2025, disclosed net bookings ranged from €2.633 billion to €13.158 billion, with a median of €5.470 billion. The two previous second quarters were close to that median: €5.567 billion in Q2 2024 and €5.541 billion in Q2 2025.
The last disclosed quarter was a record €13.158 billion in Q4 2025, including €7.4 billion of EUV orders, and ASML ended 2025 with a €38.797 billion backlog. The April 2026 release said order intake continued to be very strong. In July, management called first-half order intake “extremely strong” and said it had received close to all the EUV orders needed for 2027. The historical figures establish the scale of prior disclosures, but they are not a lower bound, upper bound or estimate for the undisclosed 2026 intake.
The capacity plan provides a separate operating reference. ASML described a 2026 base of around 65 low-numerical-aperture extreme ultraviolet, or EUV, systems and around 130 deep ultraviolet, or DUV, immersion systems, with roughly 30% more capacity planned for 2027. Applied mechanically, those rounded inputs point to capacity for about 85 low-NA EUV systems and 170 DUV immersion systems in 2027. They are ballpark capacity figures, not booked units, shipments or revenue.
ASML is also investigating another roughly 30% capacity increase for 2028. Progress will depend on supplier capacity, ASML's manufacturing execution, customer-site readiness and system acceptance. Export controls and changes in customer schedules can also affect when an order becomes reported sales.
ASML's moat remains in EUV despite DUV competition
Competition is not symmetrical across lithography. ASML's 2025 Form 20-F identifies Canon and Nikon as its principal competitors in DUV systems, while ASML says it remains the only lithography-equipment supplier producing EUV technology. That leaves ASML's moat strongest in EUV: customers requiring EUV do not currently have a second supplier of complete scanners. Canon and Nikon remain meaningful competitors in DUV, but neither is a like-for-like competitor to ASML's EUV systems.
Canon competes in krypton-fluoride, or KrF, DUV, i-line and packaging applications and is developing nanoimprint lithography as a different patterning approach. Its first-quarter 2026 results say it sold 44 semiconductor lithography systems in the quarter and expects 238 systems in 2026, up from 234 in 2025, as memory and advanced-packaging demand rises. Canon says its nanoimprint system has entered customer evaluation and validation that simulates production, with progress toward mass-production adoption in 2027. That remains a development milestone, not evidence that nanoimprint has replaced EUV in high-volume manufacturing.
Nikon is the closer optical competitor in argon-fluoride, or ArF, dry and immersion DUV. Its results for the year ended March 2026 show Precision Equipment revenue falling 17.2% to ¥167.2 billion and the segment moving from a ¥1.5 billion operating profit to a ¥4.5 billion loss, partly because of lower ArF system volumes and impairment charges. Nikon's May 2026 investor Q&A nevertheless reports strong demand and inquiries from multiple major chipmakers for its ArF systems. Canon's and Nikon's figures use different currencies, reporting periods, segment scopes and product mixes, so they show competitive direction rather than a like-for-like financial ranking.
The metrics to monitor next
Start with the third-quarter range: €11–12 billion of sales, approximately €2.9 billion of service and field-option sales, and a 55–57% gross margin. Compare the actual figures with all three measures because a higher total can come from different system, upgrade and service combinations.
Next, follow system sales, service and field-option sales, gross margin and operating margin together. The second quarter combined 17.3% system-sales growth with 31.8% service growth and a 2.5-percentage-point operating-margin increase. Future quarters will show whether that mix persists as ASML scales output.
For demand, look for the annual backlog disclosure and management's description of order coverage rather than converting qualitative language into a quarterly number. For capacity, distinguish planned capacity from systems actually ordered, shipped and accepted.
Finally, compare reported second-half sales with the €24.9–26.9 billion implied by the full-year range, and follow whether Canon reaches its lithography unit plan and Nikon converts reported ArF inquiries into improved Precision Equipment results. Those measures connect ASML's higher outlook with both execution and the competitive response.
Sources
14 references- ASML second-quarter 2026 results releaseasml.com
- ASML second-quarter 2026 US GAAP statementsourbrand.asml.com
- ASML second-quarter 2026 management transcriptourbrand.asml.com
- ASML first-quarter 2026 SEC filingsec.gov
- ASML fourth-quarter and full-year 2025 resultsasml.com
- ASML fourth-quarter and full-year 2024 management transcriptourbrand.asml.com
- ASML second-quarter 2025 SEC filingsec.gov
- ASML second-quarter 2024 SEC filingsec.gov
- ASML 2025 Form 20-F filing indexsec.gov
- ASML EUV technology explainerasml.com
- Canon first-quarter 2026 resultsglobal.canon
- Nikon results for the year ended March 2026nikon.com
- Reuters reporting on the second-quarter resultscincodias.elpais.com
- Open ASML in Helmbeamhelmbeam.com
Frequently asked questions
How has ASML's second-quarter business changed since 2024?
Second-quarter sales rose from €6.2428 billion in 2024 to €7.6917 billion in 2025 and €9.3265 billion in 2026, a 49.4% two-year increase. Service and field-option sales rose 86.4% over the same period, while gross margin increased from 51.5% to 54.0%.
How much did ASML raise its 2026 guidance?
ASML raised full-year sales guidance from €36–40 billion to €43–45 billion. The midpoint increased 15.8%, and the new range represents 31.6–37.8% growth over 2025 sales. Gross-margin guidance rose by 3.0 percentage points across the range, from 51–53% to 54–56%.
Who competes with ASML in lithography?
Canon and Nikon compete with ASML in parts of DUV lithography. Nikon is the closer optical rival in ArF dry and immersion systems, while Canon supplies KrF and i-line tools and is validating nanoimprint technology. ASML's moat remains strongest in EUV, where neither company is currently a like-for-like supplier of complete scanners.
Helmbeam is a research and analysis tool operated by Scydex Ltd. Scydex Ltd is not authorised or regulated by the Financial Conduct Authority. Helmbeam does not provide investment advice, recommendations, or solicitations to buy or sell securities. All data is for informational purposes only. Past performance of any signal, cohort, or classification does not guarantee future results. All investing involves risk, including loss of principal. Always conduct your own research and consult a qualified financial adviser before making investment decisions.
Where Helmbeam fits in the research process
Helmbeam is designed to help readers monitor changes in reported company fundamentals and valuation over time. For ASML, that means following sales mix, margins, system output, service growth and whether the higher full-year range is supported by subsequent results.
As at 15 July 2026, Helmbeam displayed ASML as IGNORE. In Helmbeam, IGNORE means no setup is active or forming for the ticker right now. It does not mean ASML is a bad company, and it is not a recommendation to buy, sell or hold the shares.
For dated historical context, Helmbeam's last recorded ASML window began on 16 April 2025 with an adjusted structural gate of US$701.79. As at 15 July 2026, the price change from that original gate to Helmbeam's latest available adjusted close was +153.02%. This is a price-only comparison from Helmbeam's window-entry reference, before trading costs, not an executed or annualised investment return, and it does not change the dated IGNORE state.
That state is a starting point, not a conclusion about the raised outlook. Subsequent results still need to show whether system output, installed-base sales, margins, order coverage and capacity execution support the higher range. Every stock is a research opportunity, but not every stock has an active setup. Open ASML in Helmbeam to check its live state, place the dated window history beside new operating evidence and see whether later data change the read. Verify material earnings details against the primary sources above.
Helmbeam is available as a free download on iOS and Android.